严重的儿科喘内型:当前的限制和未来的前景
Beatrice Andrenacci1, Maria De Filippo1,2, Martina Votto1,2
1Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Expert review of respiratory medicine
|August 30, 2023
概括
儿科重症耐治疗性喘 (STRA) 是复杂且不太了解的疾病. 研究需要多中心研究来区分内型和指导定制治疗以改善终身肺功能.
科学领域:
- 肺部病理学 肺部病理学
- 儿科过敏和免疫学
- 喘研究 喘研究
背景情况:
- 儿科重症耐治疗喘 (STRA) 是一种罕见的,异质的,资源密集的疾病,与成人喘不同.
- 儿科STRA的潜在病发性仍然不完全理解,需要进一步调查.
研究的目的:
- 在过去十年中,审查了近期定义儿科STRA内型的进展.
- 讨论当前的研究局限性,并提出儿科STRA的未来研究方向.
主要方法:
- 系统审查过去10年出版的英语书面研究.
- 专注于肺部特定的技术,如支气管膜洗和支气管内膜活检,以确定内型.
主要成果:
- 确定了儿科STRA中的异质性,突出了"适合所有人"方法的不足.
- 目前的研究受限于缺乏多中心,纵向儿科研究.
结论:
- 未来的研究必须侧重于多中心的纵向研究,以区分青春期前和青春期STRA内型.
- 针对气道改造和炎症的精确表征的早期干预对于开发有效的,量身定制的疗法和改善儿科STRA患者的长期肺功能至关重要.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
442
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
442
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342


